ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 86 filers reported holding ABEONA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,000 | +22.2% | 5,974 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +50.0% | 5,974 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -76.0% | 5,974 | -29.9% | 0.00% | – |
| Q2 2020 | $25,000 | +78.6% | 8,518 | +29.2% | 0.00% | – |
| Q1 2020 | $14,000 | -17.6% | 6,591 | +24.6% | 0.00% | – |
| Q4 2019 | $17,000 | +41.7% | 5,290 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -52.0% | 5,290 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | -35.9% | 5,290 | 0.0% | 0.00% | – |
| Q1 2019 | $39,000 | +18.2% | 5,290 | +14.2% | 0.00% | – |
| Q4 2018 | $33,000 | -44.1% | 4,632 | 0.0% | 0.00% | – |
| Q3 2018 | $59,000 | -20.3% | 4,632 | 0.0% | 0.00% | – |
| Q2 2018 | $74,000 | +1.4% | 4,632 | -9.3% | 0.00% | – |
| Q1 2018 | $73,000 | -36.5% | 5,106 | -29.4% | 0.00% | – |
| Q4 2017 | $115,000 | -1.7% | 7,233 | +8.3% | 0.00% | – |
| Q3 2017 | $117,000 | +408.7% | 6,677 | +87.6% | 0.00% | – |
| Q2 2017 | $23,000 | – | 3,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,359,767 | $3,209,000 | 1.04% |
| DAFNA Capital Management LLC | 181,818 | $429,000 | 0.34% |
| Perceptive Advisors | 1,762,881 | $4,159,000 | 0.29% |
| NEXTHERA CAPITAL LP | 100,000 | $236,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 138,105 | $326,000 | 0.08% |
| Soros Fund Management | 1,462,122 | $3,451,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 270,000 | $637,000 | 0.03% |
| CAMBRIDGE TRUST CO | 65,414 | $154,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 30,000 | $71,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 376,321 | $888,000 | 0.01% |